Can Teva Turn Things Around?

Shares of the largest generic drug company in the world, Teva Pharmaceuticals (NYSE: TEVA  ) , are down more than 7.5% in the last 12 months. This drop largely has to do with fears that biosimilars of the multiple sclerosis drug Copaxone, which currently accounts for a fifth of Teva's top line, may enter the market in the next couple of years. But what growth opportunities does the company have in the future, and what moves can it make to boost investor confidence? Analysts David Williamson and Max Macaluso discuss this topic in this segment from the Motley Fool's health-care show Market Checkup.

Looking for more dividend ideas?
One of the best parts of owning some big pharma stocks is their attractive dividends, but smart investors know the importance of diversifying -- seeking high-yielding stocks from multiple industries. The Motley Fool's special free report, "Secure Your Future With 9 Rock-Solid Dividend Stocks" outlines the Fool's favorite dependable dividend-paying stocks across all sectors. Grab your free copy by clicking here.


Read/Post Comments (2) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On September 18, 2013, at 8:26 AM, jimmymason wrote:

    I appreciate the commentator's views on Teva but I always cringe when an investor says they are going to wait for a turnaround before they invest. By then the price of the stock could be much higher. If you feel like a turnaround will happen why not buy now when the stock is low ? The comment "I am going to wait for a turnaround" smells like a buy high/sell low strategy to me.

  • Report this Comment On September 18, 2013, at 8:27 AM, jimmymason wrote:

    I appreciate the commentator's views on Teva but I always cringe when an investor says they are going to wait for a turnaround before they invest. By then the price of the stock could be much higher. If you feel like a turnaround will happen why not buy now when the stock is low ? The comment "I am going to wait for a turnaround" smells like a buy high/sell low strategy to me.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2642517, ~/Articles/ArticleHandler.aspx, 10/23/2014 4:56:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement